• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    Dynavax Technologies Corporation (DVAX)

    -NasdaqCM
    27.10 Sep 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:27.10
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:51.00
    Beta:2.42398
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:N/A - N/A
    52wk Range:13.20 - 31.10
    Volume:0
    Avg Vol (3m):605,977
    Market Cap:1.04B
    P/E (ttm):N/A
    EPS (ttm):-3.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DVAX

    Comparison

    Symbol% ChgMkt Cap
    DVAX 0.00%1.04B
    MRK147.96B
    GSK95.40B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):156.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.26
    Quarterly EPS Est (Sep-15) :-0.78
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback